Curcumin Protects Against Myocardial Infarction-Induced Cardiac Fibrosis via SIRT1 Activation in vivo and in vitro [Corrigendum]
Xiao J, Sheng X, Zhang X, Guo M, Ji X. Drug Des Devel Ther. 2016;10:1267–1277. The authors have advised due to an error at the time of figure assembly, Figure 5A on page 1274 is incorrect. The correct Figure 5 is shown in Download Article. The authors apologize for this error and advise it...
Saved in:
Main Authors: | Xiao J (Author), Sheng X (Author), Zhang X (Author), Guo M (Author), Ji X (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro
by: Xiao J, et al.
Published: (2016) -
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
by: Han X, et al.
Published: (2022) -
Geniposide Alleviates Isoproterenol-Induced Cardiac Fibrosis Partially via SIRT1 Activation in vivo and in vitro
by: Ning Li, et al.
Published: (2018) -
Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction
by: Fei Wang, et al.
Published: (2022) -
Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway [Corrigendum]
by: Zhou X, et al.
Published: (2017)